Changes in the Human Gut Microbiome during Dietary Supplementation with Modified Rice Bran Arabinoxylan Compound
Molecules · 14.07.2023 · 28 (14) · 5400
DOI: 10.3390/molecules28145400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 14.07.2023. Verfasst von Emily Schupfer und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Dentistry and Medical Sciences, Charles Sturt University, Bathurst, NSW 2795, Australia. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Oryza, Microbiota. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BioMedica Nutraceuticals Pty Ltd (Sydney, NSW, Australia).
Abstract (Originalsprache)
This study investigated the effects of a modified rice bran arabinoxylan compound (RBAC) as a dietary supplement on the gut microbiota of healthy adults. Ten volunteers supplemented their diet with 1 g of RBAC for six weeks and 3 g of RBAC for another six weeks, with a three-week washout period. Faecal samples were collected every 3 weeks over 21 weeks. Microbiota from faecal samples were profiled using 16S rRNA sequencing. Assessment of alpha and beta microbiota diversity was performed using the QIIME2 platform. The results revealed that alpha and beta diversity were not associated with the experimental phase, interventional period, RBAC dosage, or time. However, the statistical significance of the participant was detected in alpha (p < 0.002) and beta (weighted unifrac, p = 0.001) diversity. Explanatory factors, including diet and lifestyle, were significantly associated with alpha (p < 0.05) and beta (p < 0.01) diversity. The individual beta diversity of six participants significantly changed (p < 0.05) during the interventional period. Seven participants showed statistically significant taxonomic changes (ANCOM W ≥ 5). These results classified four participants as responders to RBAC supplementation, with a further two participants as likely responders. In conclusion, the gut microbiome is highly individualised and modulated by RBAC as a dietary supplement, dependent on lifestyle and dietary intake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Dentistry and Medical Sciences, Charles Sturt University, Bathurst, NSW 2795, Australia.
- School of Science, Western Sydney University, Penrith, NSW 2751, Australia.
- School of Dentistry and Medical Sciences, Charles Sturt University, Orange, NSW 2800, Australia.
- Ageing Well Research Group, Charles Sturt University, Orange, NSW 2800, Australia.
- School of Dentistry and Medical Sciences, Charles Sturt University, Port Macquarie, NSW 2444, Australia.
ORCID-Profile: Emily Schupfer, Soo Liang Ooi, Thomas C Jeffries, Shaoyu Wang, Peter S Micalos, Sok Cheon Pak
Förderung
- BioMedica Nutraceuticals Pty Ltd (Sydney, NSW, Australia)
Zitieren
APA
Schupfer, E., Ooi, S. L., Jeffries, T. C., Wang, S., Micalos, P. S., & Pak, S. C. (2023). Changes in the Human Gut Microbiome during Dietary Supplementation with Modified Rice Bran Arabinoxylan Compound. Molecules, 28(14), 5400. https://doi.org/10.3390/molecules28145400
Vancouver
Schupfer E, Ooi SL, Jeffries TC, Wang S, Micalos PS, Pak SC. Changes in the Human Gut Microbiome during Dietary Supplementation with Modified Rice Bran Arabinoxylan Compound. Molecules. 2023;28(14):5400. doi:10.3390/molecules28145400
BibTeX
@article{Schupfer2023,
author = {Schupfer, Emily and Ooi, Soo Liang and Jeffries, Thomas C and Wang, Shaoyu and Micalos, Peter S and Pak, Sok Cheon},
title = {Changes in the Human Gut Microbiome during Dietary Supplementation with Modified Rice Bran Arabinoxylan Compound},
journal = {Molecules},
year = {2023},
volume = {28},
number = {14},
pages = {5400},
doi = {10.3390/molecules28145400}
}
EUVIMED